The role of c-Myc on granulocyte colony-stimulating factor-dependent neutrophilic proliferation and differentiation of HL-60 cellsKANAYASU-TOYODA, Toshie; YAMAGUCHI, Teruhide; OSHIZAWA, Tadashi et al.Biochemical pharmacology. 2003, Vol 66, Num 1, pp 133-140, issn 0006-2952, 8 p.Article

TIP49, but not TRRAP, modulates c-Myc and E2F1 dependent apoptosisDUGAN, Kerri A; WOOD, Marcelo A; COLE, Michael D et al.Oncogene (Basingstoke). 2002, Vol 21, Num 38, pp 5835-5843, issn 0950-9232, 9 p.Article

Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in miceJIANXIA GUO; PARISE, Robert A; JOSEPH, Erin et al.Cancer chemotherapy and pharmacology. 2009, Vol 63, Num 4, pp 615-625, issn 0344-5704, 11 p.Article

Synergistic and opposing regulation of the stress-responsive gene IEX-1 by p53, c-Myc, and multiple NF-κB/rel complexesHUANG, Yan-Hong; JIM YUJIN WU; YUJIN ZHANG et al.Oncogene (Basingstoke). 2002, Vol 21, Num 44, pp 6819-6828, issn 0950-9232, 10 p.Article

Régulation de la transcription du gène E4 de l'adenovirus de type 2Gilardi, Pascale; Cohen, Paul.1989, 150 p.Thesis

Effects of FK228, a novel histone deacetylase inhibitor, on tumor growth and expression of p21 and c-myc genes in vivoSASAKAWA, Yuka; NAOE, Yoshinori; INOUE, Takeshi et al.Cancer letters. 2003, Vol 195, Num 2, pp 161-168, issn 0304-3835, 8 p.Article

c-Myc overexpression and endocrine resistance in breast cancerMCNEIL, Catriona M; SERGIO, C. Marcelo; GARDINER-GARDEN, Margaret et al.Journal of steroid biochemistry and molecular biology. 2006, Vol 102, Num 1-5, pp 147-155, issn 0960-0760, 9 p.Conference Paper

Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene productQI LUO; JUN LI; CENKCI, Belgin et al.Oncogene (Basingstoke). 2004, Vol 23, Num 5, pp 1088-1097, issn 0950-9232, 10 p.Article

Conserved features of cancer cells define their sensitivity to HAMLET-induced death; c-Myc and glycolysisSTORM, P; AITS, S; SULLIVAN, N. L et al.Oncogene (Basingstoke). 2011, Vol 30, Num 48, pp 4765-4779, issn 0950-9232, 15 p.Article

Pim kinase-dependent inhibition of c-Myc degradationZHANG, Y; WANG, Z; LI, X et al.Oncogene (Basingstoke). 2008, Vol 27, Num 35, pp 4809-4819, issn 0950-9232, 11 p.Article

Nfkbl is dispensable for Myc-induced lymphomagenesisKELLER, Ulrich; NILSSON, Jonas A; MACLEAN, Kirsteen H et al.Oncogene (Basingstoke). 2005, Vol 24, Num 41, pp 6231-6240, issn 0950-9232, 10 p.Article

12-N-Methylated 5,6-dihydrobenzo[c]acridine derivatives: A new class of highly selective ligands for c-myc G-quadruplex DNALIAO, Sheng-Rong; ZHOU, Chen-Xi; WU, Wei-Bin et al.European journal of medicinal chemistry. 2012, Vol 53, pp 52-63, issn 0223-5234, 12 p.Article

C-myc, C-fos, and C-ras coding sequences are conserved from yeast to mammalsDUTTA, S. K; VERMA, M.Cancer biochemistry biophysics. 1993, Vol 13, Num 3, pp 181-185, issn 0305-7232Article

Déterminants structuraux de l'instabilité des messagers c-myc et c-fosBonnieu, Anne; Jeanteur, Philippe.1988, 120 p.Thesis

Interaction fer et hépatocytes en culture: régulation des protéines du métabolism du fer et toxicité cellulaire = Interaction iron and hepatocytes in culture: regulation of iron metabolism proteins and cellular toxicityHubert, Noella; Lescoat, Gérard.1992, 94 p.Thesis

The human c-myc oncogene: structural consequences of translocation into the IgH locus in Burkitt lymphomaBATTEY, J; MOULDING, C; TAUB, R et al.Cell (Cambridge). 1983, Vol 34, Num 3, pp 779-787, issn 0092-8674Article

An early decrease in phosphatidylinositol turnover occurs on induction of friend cell differentiation and precedes the decrease in c-myc expressionFALETTO, D. L; ARROW, A. S; MACARA, I. G et al.Cell (Cambridge). 1985, Vol 43, Num 1, pp 315-325, issn 0092-8674Article

c-myc gene expression is stimulated by agents that activate protein kinase C and does not account for the mitogenic effect of PDGFCOUGHLIN, S. R; LEE, W. M. F; WILLIAMS, P. W et al.Cell (Cambridge). 1985, Vol 43, Num 1, pp 243-251, issn 0092-8674Article

c-MYC activates protein kinase A (PKA) by direct transcriptional activation of the PKA catalytic subunit beta (PKA-Cβ) geneWU, Kou-Juey; MATTIOLI, Michela; MORSE, Herbert C et al.Oncogene (Basingstoke). 2002, Vol 21, Num 51, pp 7872-7882, issn 0950-9232, 11 p.Article

A simultaneous flow cytometric assay for c-myc oncoprotein and DNA in nuclei from paraffin embedded materialWATSON, J. V; SIKORA, K; EVAN, G. I et al.Journal of immunological methods. 1985, Vol 8, Num 1, pp 179-192, issn 0022-1759Article

Apoptosis and differentiation of human embryonic stem cells induced by sustained activation of c-MycSUMI, T; TSUNEYOSHI, N; NAKATSUJI, N et al.Oncogene (Basingstoke). 2007, Vol 26, Num 38, pp 5564-5576, issn 0950-9232, 13 p.Article

The aryl hydrocarbon receptor constitutively represses c-myc transcription in human mammary tumor cellsXINHAI YANG; DONGHUI LIU; MURRAY, Tessa J et al.Oncogene (Basingstoke). 2005, Vol 24, Num 53, pp 7869-7881, issn 0950-9232, 13 p.Article

E2F activity is essential for survival of Myc-overexpressing human cancer cellsSANTONI-RUGIU, Eric; DURO, Dominique; FARKAS, Thomas et al.Oncogene (Basingstoke). 2002, Vol 21, Num 42, pp 6498-6509, issn 0950-9232, 12 p.Article

Aberrant ribosome biogenesis activates c-Myc and ASK1 pathways resulting in p53-dependent G1 arrestKIM, H. D; KIM, T.-S; KIM, J et al.Oncogene (Basingstoke). 2011, Vol 30, Num 30, pp 3317-3327, issn 0950-9232, 11 p.Article

Transcriptional regulation of Wnt inhibitory factor-1 by Miz-1/c-MycLICCHESI, Jdf; VAN NESTE, L; TIWARI, V. K et al.Oncogene (Basingstoke). 2010, Vol 29, Num 44, pp 5923-5934, issn 0950-9232, 12 p.Article